Resolution criteria on PolyGram: This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify.
PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.
Market outcomes
| Sara Brenner | 4% YES | 96% NO |
| Other | — | |
| Person B | — | |
| Person D | — | |
| Person F | — | |
| Person H | — | |
| Person J | — | |
| Person L | — | |
Donald Trump will need to select and announce a commissioner for the Food and Drug Administration during his second term, which began in January 2025. The FDA commissioner role requires Senate confirmation and oversees the agency's regulation of pharmaceuticals, medical devices, food safety, and tobacco products. The announcement itself—distinct from formal nomination or confirmation—is the triggering event for this market, meaning Trump's public statement of intent to nominate a specific individual suffices for resolution.
Historical precedent suggests FDA commissioner selections often emerge within the first six months of a presidential term, though timelines vary considerably. During Trump's first term, Scott Gottlieb was announced in March 2017 and confirmed later that year. The current 5% implied probability on Polymarket's order book reflects relatively low conviction that an announcement will occur by the settlement deadline of 31 December 2026, suggesting either low expected probability of announcement within that window or substantial uncertainty about the eventual nominee's identity. Comparable regulatory appointments under Trump have sometimes faced delays due to vetting processes or competing priorities.
Traders should monitor Trump administration statements, particularly from the Department of Health and Human Services and the White House. Key catalysts include formal nomination announcements, which typically precede Senate confirmation hearings by weeks. Recent reporting on potential candidates and Trump's regulatory philosophy—particularly regarding drug approval timelines and pharmaceutical industry relations—may signal imminent announcements. The market's low probability may reflect either genuine uncertainty about timing or market participants' assessment that announcement is unlikely within the specified window.
Resolution is handled by the UMA optimistic oracle on Polygon. A proposer submits the outcome, a two-hour dispute window opens, and if no one stakes a counter-claim the payout is final. Contested outcomes escalate to UMA token-holder voting. Payouts clear in USDC to the winning side.
The mechanics for trading "Who will Trump announce as next FDA commissioner?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.
$870 in lifetime turnover and $6K of resting liquidity puts this market in the below the median by volume for fda contracts on PolyGram. Order-book depth is thin — large orders may need to be split across the book or executed as limit orders.
Last 24 hours alone saw $866 in turnover, well above the lifetime daily-average for this market — a clear sign of news catalysing trader activity right now.
The market has been open for under a month — fresh enough that information asymmetry remains a real factor.
Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.
Resolution is handled by the UMA optimistic oracle on Polygon. A proposer submits the outcome, a 2-hour dispute window opens, and if uncontested the payout is final. Contested outcomes escalate to UMA token holders.
This prediction market is scheduled to close on 31 December 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.
To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.
When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.
Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.
Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.
Explore more prediction market odds and trading opportunities on PolyGram: